Monte Rosa Therapeutics, Inc. (GLUE) Tops Q3 EPS by 2c
Get Alerts GLUE Hot Sheet
Join SI Premium – FREE
Monte Rosa Therapeutics, Inc. (NASDAQ: GLUE) reported Q3 EPS of ($0.70), $0.02 better than the analyst estimate of ($0.72).
For earnings history and earnings-related data on Monte Rosa Therapeutics, Inc. (GLUE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Broadcom credit risk measures rise amid AI financing deals
- Nebius Group closes $5.75B convertible notes offering
- DA Davidson Reiterates Buy Rating on Wabash National (WNC)
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share